Common Side Effects of Mounjaro: What Actually Happens and When to Act

GI side effects are the most commonly reported with Mounjaro; they are typically most noticeable at the start of treatment or after each dose step-up, then settle for most people.
Serious side effects (including acute pancreatitis) are infrequent but real; the MHRA issued a formal Drug Safety Update on GLP-1 medicines and pancreatitis in January 2026.
Patients can report suspected side effects directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.
If you are prescribed Mounjaro through nume, our prescribers and aftercare team are available seven days a week to answer safety questions as they come up.

The most common side effects of Mounjaro are gastrointestinal: nausea, diarrhoea, constipation, vomiting, indigestion and stomach discomfort. These affect a significant proportion of people, particularly in the first few weeks after starting or after a dose increase, and they usually settle as the body adjusts. Mounjaro (tirzepatide) is a prescription-only medicine; a prescriber assesses your full medical picture before it is issued, and side effects are part of that clinical conversation. This page covers what the evidence shows, what tends to pass on its own, and — critically — which symptoms need prompt medical attention.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The full picture on Mounjaro side effects: what's common, what's rare, and what needs urgent attention

The biggest myth: side effects mean something has gone wrong

The most persistent misconception about Mounjaro side effects is that experiencing nausea or loose stools in the first couple of weeks signals a problem with the medicine, or that you should stop taking it straight away. In the vast majority of cases, the opposite is true. These reactions reflect the medicine working as intended: tirzepatide slows gastric emptying and changes gut-hormone signalling, and those same mechanisms are what drive appetite reduction and weight loss. The body needs a short period to recalibrate.

The licensed dosing structure builds this in deliberately. Treatment begins at 2.5 mg, a dose whose primary job is letting your system adapt, not yet delivering the full therapeutic effect. As the NHS tirzepatide medicines page explains, GI symptoms are expected at the start and tend to improve with time. Most people find the nausea most noticeable in the day or two after an injection, then fading over the following days. By the time a dose increase is reached (typically at four-week intervals under a prescriber's guidance) many people report tolerating it well.

That said, the myth runs in both directions. Some people start Mounjaro expecting severe nausea and are pleasantly surprised; others are caught off guard. Knowing what is normal, what typically passes, and what falls outside that range is the useful preparation. The sections below cover exactly that, drawing on the medicine's SmPC and clinical trial data.

What the common side effects of Mounjaro actually look like day to day

Across the SURMOUNT clinical programme, the most frequently reported side effects were nausea, diarrhoea, vomiting, constipation, abdominal pain, dyspepsia (indigestion) and burping. Fatigue, headache, dizziness and injection-site reactions also appeared, though less often. These findings are consistent with what the Mounjaro SmPC on the eMC lists as common adverse effects.

In practical terms, nausea tends to arrive in the first day or so after an injection and ease off by day three or four. Constipation, when it occurs, can be more persistent, staying well hydrated and keeping fibre intake up makes a noticeable difference for many people. Diarrhoea is less common than constipation overall, though it can occur, particularly at higher doses. Injection-site reactions (mild redness or itching at the abdomen, thigh or upper arm) are generally transient and improve with rotating the site each week.

Hair thinning is another concern that comes up regularly. It is not listed as a common adverse effect of tirzepatide itself; rather, it is associated with rapid weight loss generally (a condition called telogen effluvium), and it is usually temporary. There is a fuller explanation of hair loss on Mounjaro if that is a specific concern for you.

One thing our prescribers hear most weeks: people worried that a single bad night of nausea means they cannot continue. Usually that is not the case, pacing meals, eating smaller portions, and avoiding fatty or very rich food in the hours around an injection all help. Your prescriber and the Patient Information Leaflet are the right places to get personalised support on managing these effects.

When to get medical help: symptoms that should not wait

Not every side effect is something to ride out. Some require prompt medical attention, and it is important to know which.

The MHRA's January 2026 Drug Safety Update for GLP-1 medicines specifically highlighted acute pancreatitis as an infrequent but potentially serious side effect. The warning sign to act on is severe, persistent stomach pain (the kind that does not settle and may radiate through to the back) with or without vomiting. If that happens, stop taking your next dose and seek urgent medical attention. Do not wait to see whether it passes on its own.

Other symptoms that warrant contacting a doctor promptly include: signs of a serious allergic reaction (swelling of the face, lips, tongue or throat; difficulty breathing; rash); symptoms suggesting gallbladder problems (sudden pain in the upper right abdomen, especially after eating); and signs of significant dehydration following severe vomiting or diarrhoea, such as very little or no urination, confusion or extreme dizziness. If you are also being treated for diabetes, low blood sugar is an additional consideration to discuss with your prescriber.

Side effects can also be reported directly to the MHRA via the Yellow Card scheme, this applies both to reactions you experience yourself and to any medicine you suspect may be counterfeit or substandard. It is a straightforward online process and genuinely useful for post-market surveillance.

For a broader look at Mounjaro side effects across all categories, including less common reactions, the dedicated overview page covers more ground. The BNF listing for tirzepatide side effects is the professional-level reference if you want the full clinical detail.

Starting Mounjaro through a regulated UK service: how safety stays central

Because Mounjaro is a prescription-only medicine, the clinical assessment before it is issued is not a formality. At nume, a GPhC-registered Independent Prescriber reads your consultation answers personally, the same day, not via automated software. They look at your medical history, current medicines and any contraindications before approving treatment, and they factor the likely side-effect profile into that decision.

Our prescribers discuss suitability and anticipated side effects as part of every consultation. If you are already taking Mounjaro elsewhere and considering switching, or if you want to understand how the tirzepatide side-effect profile compares across the available evidence, that is all part of what the free consultation covers. You can also review how Mounjaro works and what the treatment involves before you start.

After treatment is issued, our aftercare team is available seven days a week. That matters in practice: if nausea hits on a Saturday afternoon before the school run, you do not need to wait until Monday to ask whether it is expected. If you have questions about cost alongside clinical questions, Mounjaro pricing at nume is set out clearly. And if you are ready to talk through suitability, start your free consultation and speak to our prescribers directly.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions